Livagen
Fat LossKhavinson liver bioregulator / researchExperimental
Short peptide marketed as a hepatic bioregulator. Not FDA-approved.
For research use only.
Key Facts
- CAS
- —
- Molecular Weight (MW)
- —
- Half-life
- —
- Unit
- mg
- Administration Route
- Subcutaneous
- Frequency
- —
- Last updated
- Aug 23, 2026
- Targets
- Hepatocytes (proposed)
Vendor price snapshot
Price per mg is list price divided by vial size in milligrams when both are known from public vendor listings. Peptide Library does not sell peptides. Confirm live prices on the vendor site.
- Vendors listing this peptide
- 1
- Listed offers
- 1
- Price per mg range
- $2.50/mg
Overview
Short peptide marketed as a hepatic bioregulator. Not FDA-approved.
Protocol
- Dosage Range
- Vendor research protocols only
- Frequency
- —
- Cycle
- —
- Administration Route
- Subcutaneous
- Reconstitution Guide
- —
- Injection Sites
- AbdomenThigh
- Timing Notes
- Educational catalog only — not medical advice
Science
Mechanism of Action
Claimed hepatocyte gene-expression effects in Khavinson-series literature.
Origin
Synthetic short peptide.
Targets
Hepatocytes (proposed)
Studies
Benefits
Historical liver-bioregulator category
Potential Side Effects
Side Effects
- Not characterized
References
- PMID 15587334External reference